Picture of Level Bio AB (publ) logo

LEVBIO Level Bio AB (publ) Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Level Bio AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSPRESSARSARSPRESS
Standards:
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line5.21-2.41-9.69-8.19-3.57
Depreciation
Non-Cash Items0.4920.9021.880.112.48
Unusual Items
Other Non-Cash Items
Changes in Working Capital-5.342.20.1771.441.91
Change in Accounts Receivable
Change in Inventories
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities1.632.87-5.45-4.460.82
Capital Expenditures-0.288-0.0430
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-4.34-0.30.7710
Acquisition of Business
Sale of Fixed Assets
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-4.34-0.5880.7280
Financing Cash Flow Items-0.6450-0.1460.001
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities7.16-0.30.5071.910.586
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash4.441.98-4.21-2.551.41